On a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab...
LONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline said Friday that their potential COVID-19 vaccine won’t be ready until late next year because they need to improve the shot’s effectiveness in older people...
RIO DE JANEIRO (AP) — Night began to fall in Rio de Janeiro’s Pedra Branca state park as four Brazilian scientists switched on their flashlights to traipse along a narrow trail of mud through dense rainforest...
Amid the chaos of the pandemic’s early days, doctors who faced the first coronavirus onslaught reached across oceans and language barriers in an unprecedented effort to advise colleagues trying to save lives in the dark...
NEW YORK (AP) — What is this enemy?
Seven months after the first patients were hospitalized in China battling an infection doctors had never seen before, the world’s scientists and citizens have reached an unsettling crossroads...
Desperate to solve the deadly conundrum of COVID-19, the world is clamoring for fast answers and solutions from a research system not built for haste...
One of the great mysteries of the coronavirus is how quickly it rocketed around the world.
It first flared in central China and, within three months, was on every continent but Antarctica, shutting down daily life for millions...
NEW DELHI (AP) — The coronavirus pandemic is a “wake up call” for governments to invest more in health care, says Adar Poonawalla, CEO of the Serum Institute of India, the world’s largest manufacturer of vaccines...
WASHINGTON (AP) — As states frantically prepare to begin months of vaccinations that could end the pandemic, a new poll finds only about half of Americans are ready to roll up their sleeves when their turn comes...
New results on a possible COVID-19 vaccine from Oxford University and AstraZeneca suggest it is safe and about 70% effective, but questions remain about how well it may help protect those over 55 — a key concern for a vaccine that health officials hope to rely on around the world because of its low cost, availability and ease of use...
How could scientists race out COVID-19 vaccines so fast without cutting corners? A head start helped -- over a decade of behind-the-scenes research that had new vaccine technology poised for a challenge just as the coronavirus erupted...
Getting a COVID-19 vaccine to the right people could change the course of the pandemic in the United States...
LONDON (AP) — British regulators have become the first to authorize the COVID-19 vaccine developed by American drugmaker LONDON (AP) — The British government said Friday it has formally asked the country’s medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be authorized for use.
LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine...
Two COVID-19 vaccines might be nearing the finish line, but scientists caution it's critical that enough people volunteer to help finish studying other candidates in the U...
MOSCOW (AP) — Developers of Sputnik V, Russia's experimental COVID-19 vaccine, announced Wednesday that early, interim data from a large trial suggests the shot appears to be 92% effective...
WASHINGTON (AP) — Federal health officials on Friday unveiled a plan to get yet-to-be-approved coronavirus vaccines to nursing home residents free of charge, enlisting two national pharmacy chains to help...
NEW YORK (AP) —
Pfizer Inc. cannot request emergency authorization of its COVID-19 vaccine before the third week of November -- and that’s if everything goes well, the company’s CEO announced Friday...
TAIPEI, Taiwan (AP) — China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad...
Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available — an added safety layer experts call vital...
The head of Pfizer, one of the drugmakers racing to develop a coronavirus vaccine, told employees on Thursday he was disappointed that its work was politicized during the presidential debate and tried to reassure U...
BEIJING (AP) — A Chinese health official said Friday that the country's annual production capacity for coronavirus vaccines will top 1 billion doses next year, following an aggressive government support program for construction of new factories...
TAKOMA PARK, Md. (AP) — In front of baskets of tomatoes and peppers, near a sizzling burrito grill, the “promotoras” stop masked shoppers at a busy Latino farmers market: Want to test a COVID-19 vaccine...
BERLIN (AP) — Germany says it is providing up to 750 million euros ($892 million) to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus...
LONDON (AP) — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U...
LONDON (AP) — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday...
The top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus signed an unprecedented pledge meant to boost public confidence in any approved vaccines...
LONDON (AP) — The head of the World Health Organization said the U.N. health agency will not recommend any COVID-19 vaccine before it is proved safe and effective, even as Russia and China have started using their experimental vaccines before large studies have finished and other countries have proposed streamlining authorization procedures...
MOSCOW (AP) — Russian scientists have belatedly published first results from early trials into the experimental Sputnik V vaccine, which received government approval last month but drew considerable criticism from experts, as the shots had only been tested on several dozen people before being more widely administered...
Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found...
A handful of the dozens of experimental COVID-19 vaccines in human testing have reached the last and biggest hurdle — looking for the needed proof that they really work as a U...
LONDON (AP) — Britain is preparing to revise its laws to allow the emergency use of any effective coronavirus vaccine before it is fully licensed — but only if the shots meet required safety and quality standards...
CANBERRA, Australia (AP) — Papua New Guinea blocked the arrival of a flight carrying workers from China after a Chinese mine operator said its employees were given a coronavirus vaccine in a possible unauthorized trial, authorities said Friday...
LONDON (AP) — The World Health Organization’s Europe office said it has begun discussions with Russia to try to obtain more information about the experimental COVID-19 vaccine the country recently approved...
A doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot...
JAKARTA, Indonesia (AP) — More people in Indonesia rolled up their sleeves Friday to test a potential coronavirus vaccine developed by a Chinese company...
With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them...
WASHINGTON (AP) — No, Russia isn't having a Sputnik moment.
The announcement Tuesday by Russian President Vladimir Putin that MOSCOW (AP) — Russia boasts that it’s about to become the first country to approve a COVID-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire...
Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision...
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works...
LONDON (AP) — Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far...
Amid the chaos of the pandemic’s early days, doctors who faced the first coronavirus onslaught reached across oceans and language barriers in an unprecedented effort to advise colleagues trying to save lives in the dark...
The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U...
WASHINGTON (AP) — The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, Health and Human Services Secretary Alex Azar announced Wednesday...
New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection also is gone or that it won’t be possible to develop an effective vaccine...
LONDON (AP) — Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot...